Zeev's Turnips Patch-No Politics (ZEEV)

[Bruce A Thompson]

Geron Corporation Announces Common Stock Offering of Five Million Shares

MENLO PARK, Calif.--(BUSINESS WIRE)--October 15, 2003--Geron
Corporation (Nasdaq: GERN) today announced its plans to publicly
offer five million shares of its common stock in an offering made
from a shelf registration statement that became effective in February
2002.

UBS Securities LLC is acting as the sole book running manager in
this offering. SG Cowen Securities Corporation, Lazard and Needham &
Company, Inc. are acting as co-managers. Geron would also grant to the
underwriters an option to purchase an additional 750,000 shares of
common stock to cover over-allotments.

This press release does not constitute an offer to sell or the
solicitation of an offer to buy any of these securities. This offering
of common stock may be made only by means of a prospectus, a copy of
which will be available from UBS Securities LLC, ECMG Syndicate, 299
Park Avenue, New York, New York 10171.

Geron is a biopharmaceutical company focused on developing and
commercializing therapeutic and diagnostic products for cancer based
on its telomerase technology, and cell-based therapeutics using its
human embryonic stem cell technology.